New Therapeutic Protocol

A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
details

Bio-immunotherapy of mesothelioma: clinical use of new therapeutic targets. In vitro data and the first clinical results.
details

Phase II study on the activity of trabectedin in pretreated epithelioid or biphasic/sarcomatoid malignant pleural mesothelioma (mpm)
details